Predictive Factors of Detectable Viral Load in HIV-Infected Patients.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 21 9 2021
medline: 19 7 2022
entrez: 20 9 2021
Statut: ppublish

Résumé

Despite availability of effective antiretroviral therapy (ART), many HIV patients still have a detectable viral load (VL). Predictive factors of detectable VL are not well documented. This study was done at two large multidisciplinary HIV outpatient clinics at the Centre hospitalier de l'Université de Montréal (CHUM) and the McGill University Health Centre (MUHC). This is a retrospective case-control study of patients treated between 2016 and 2018. Cases had a VL ≥50 copies/mL in 2018. Controls had an undetectable VL from 2016 to 2018. Matching was based on gender and year of HIV diagnosis. Primary objective was to identify predictive factors of detectable VL. Secondary objectives included to identify predictive factors of virologic failure, low persistent viremia, and viral blip. A forward stepwise model selection by the Akaike Information Criterion of the conditional logistic regression was used to identify predictive factors. Two hundred cases were identified and matched with 200 controls. The cohort was mostly male (68.0%) with a median age of 54 years (21-83 years). Among cases, viral blip was the most common type of detectable VL (43.0%). The strong predictive factors for a detectable VL were adherence to ART and seeking health care services. Asylum seekers were less at risk of detectable VL. Adherence to ART was the only strong predictive factor for virologic failure. Three main predictive factors of detectable VL were identified in two ambulatory clinic hospitals in Montreal. Ascertaining these factors will allow for identification of patients more at risk of detectable VL.

Identifiants

pubmed: 34538065
doi: 10.1089/AID.2021.0106
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

552-560

Auteurs

Audrey Bouchard (A)

Pharmacy Department, University of Montreal Hospital Center, Montreal, Canada.
Pharmacy Faculty, University of Montreal, Montreal, Canada.

François Bourdeau (F)

Pharmacy Department, University of Montreal Hospital Center, Montreal, Canada.
Pharmacy Faculty, University of Montreal, Montreal, Canada.

Julien Roger (J)

Pharmacy Department, University of Montreal Hospital Center, Montreal, Canada.
Pharmacy Faculty, University of Montreal, Montreal, Canada.

Vincent-Thierry Taillefer (VT)

Pharmacy Department, University of Montreal Hospital Center, Montreal, Canada.
Pharmacy Faculty, University of Montreal, Montreal, Canada.

Nancy L Sheehan (NL)

Pharmacy Faculty, University of Montreal, Montreal, Canada.
Chronic Viral Illness Service, and McGill University Health Centre, Montreal, Canada.
Pharmacy Department, McGill University Health Centre, Montreal, Canada.

Mireille Schnitzer (M)

Pharmacy Faculty, University of Montreal, Montreal, Canada.

Guanbo Wang (G)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Imma Judy Jean Baptiste François (IJ)

Pharmacy Faculty, University of Montreal, Montreal, Canada.

Rachel Therrien (R)

Pharmacy Department, University of Montreal Hospital Center, Montreal, Canada.
Pharmacy Faculty, University of Montreal, Montreal, Canada.
Chronic Viral Illness Service, University of Montreal Hospital Center, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH